Abstract:Novel coronavirus disease 2019 (COVID-19) is a global pandemic caused by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), which can be transmitted from person to person. As of September 21, 2021, over 228 million cases were diagnosed as COVID-19 infection in more than 200 countries and regions worldwide. The death toll is more than 4.69 million and the mortality rate has reached about 2.05% as it has gradually become a global plague, and the numbers are growing. Therefore, it is important to gain a deeper understanding of the genome and protein characteristics, clinical diagnostics, pathogenic mechanisms, and the development of antiviral drugs and vaccines against the novel coronavirus to deal with the COVID-19 pandemic. The traditional biology technologies are limited for COVID-19-related studies to understand the pandemic happening. Bioinformatics is the application of computational methods and analytical tools in the field of biological research which has obvious advantages in predicting the structure, product, function, and evolution of unknown genes and proteins, and in screening drugs and vaccines from a large amount of sequence information. Here, we comprehensively summarized several of the most important methods and applications relating to COVID-19 based on currently available reports of bioinformatics technologies, focusing on future research for overcoming the virus pandemic. Based on the next-generation sequencing (NGS) and third-generation sequencing (TGS) technology, not only virus can be detected, but also high quality SARS-CoV-2 genome could be obtained quickly. The emergence of data of genome sequences, variants, haplotypes of SARS-CoV-2 help us to understand genome and protein structure, variant calling, mutation, and other biological characteristics. After sequencing alignment and phylogenetic analysis, the bat may be the natural host of the novel coronavirus. Single-cell RNA sequencing provide abundant resource for discovering the mechanism of immune response induced by COVID-19. As an entry receptor, angiotensin-converting enzyme 2 (ACE2) can be used as a potential drug target to treat COVID-19. Molecular dynamics simulation, molecular docking and artificial intelligence (AI) technology of bioinformatics methods based on drug databases for SARS-CoV-2 can accelerate the development of drugs. Meanwhile, computational approaches are helpful to identify suitable vaccines to prevent COVID-19 infection through reverse vaccinology, Immunoinformatics and structural vaccinology.

Bioinformatics resources for SARS-CoV-2 discovery and surveillance

Bioinformatics resources facilitate understanding and harnessing clinical research of SARS-CoV-2.

OverCOVID: an Integrative Web Portal for SARS-CoV-2 Bioinformatics Resources

Comprehensive analyses of bioinformatics applications in the fight against COVID-19 pandemic

Applying the Digital Data and the Bioinformatics Tools in SARS-CoV-2 Research

Bioinformatics research on the SARS coronavirus (SARS_CoV) in China.

Bioinformatics for the Origin and Evolution of Viruses.

A database resource and online analysis tools for coronaviruses on a historical and global scale

An online coronavirus analysis platform from the National Genomics Data Center

A Coronavirus Online Analysis Platform at the National Genomics Data Center

The emergence, genomic diversity and global spread of SARS-CoV-2

The Global Landscape of SARS-CoV-2 Genomes, Variants, and Haplotypes in 2019nCoVR

Next-Generation Bioinformatics Approaches and Resources for Coronavirus Vaccine Discovery and Development—A Perspective Review

The Relevance of Bioinformatics Applications in the Discovery of Vaccine Candidates and Potential Drugs for COVID-19 Treatment

SARS2020: an integrated platform for identification of novel coronavirus by a consensus sequence-function model

The 2019 novel coronavirus resource.

RCoV19: A One-stop Hub for SARS-CoV-2 Genome Data Integration, Variant Monitoring, and Risk Pre-warning

In silico genomic surveillance by CoVerage predicts and characterizes SARS-CoV-2 Variants of Interest

A Survey on Computational Methods in Discovering Protein Inhibitors of SARS-CoV-2

Global landscape of SARS-CoV-2 genomic surveillance and data sharing

Comparative Bioinformatic Analysis Reveals Conserved Regions in SARS-CoV-2 Genome for RAPID Pandemic Response